# Aquestive Therapeutics, Inc.: Form 8-K, filed Feb 12, 2025

- Company: [Aquestive Therapeutics, Inc.](/companies/aqst.md) (CIK 1398733)
- Form: 8-K
- Filed: 2025-02-12
- Accepted by EDGAR: Feb 12, 2025, 12:22 ET
- Period: 2025-02-12
- Accession: 0001628280-25-005018
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1398733/000162828025005018/aqst-20250212.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1398733/000162828025005018/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1398733/000162828025005018/aqst-20250212.htm

Filed Feb 12, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-005018. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.